Health
Food and Drug Administration Critically Scrutinizing Emergency Vaccines by Johnson and Johnson Pharmaceuticals
Despite the groundbreaking success in getting the COVID-19 vaccines invented and ready for mass distribution, there is still a long way to go in curbing the spread of the virus. For instance, the United States has vaccinated no more than 7 percent of the entire population.
As a result, the 2 major pharmaceutical companies charged with the responsibility of producing COVID-19 vaccines could use some help. This is where the Johnson and Johnson emergency vaccines come to play.
Peculiarities of the Johnson and Johnson Vaccines
Unlike what is required with the 2 approved pharmaceutical companies, the Johnson and Johnson vaccine only requires one dose. As a result, the logistical complications of rescheduling and administering a second dose are sorted out.
Furthermore, a recent briefing by...